Curatio, a digital health company that has developed the world’s first social health prescription to tackle loneliness and isolation, has raised a Series A round. The amount of funding has not been disclosed.
The round was led by Rhino with participation from Conexus Venture Capital Fund. Used in over 85 countries and available in 5 languages, Curatio provides health organizations with a way to create their own private social networks for patients using a privacy and regulatory compliant software platform. With this new funding, Curatio will continue its global expansion and grow their team to help meet substantial pent up demand from the healthcare sector.
“Right now, the entire world is experiencing the type of isolation that millions of patients face every day. We know that when patients and their families are provided with peer support and daily disease management tools they have improved health outcomes, higher adherence, and better quality of life. What we have built at Curatio is a way to deliver that type of support at scale on a platform that is designed for the highest level of privacy and regulatory compliance required by healthcare. With COVID-19, Curatio’s solution is needed to keep patients healthy at home and help healthcare organizations rapidly transition to virtual delivery.” Lynda Brown-Ganzert, Curatio CEO & Co-Founder
Rhino is known for investing early in audacious founders tackling problems with asymmetric market potential. We were compelled by the unique needs of a vertical-specific social network vs. incumbent solutions and, after becoming acquainted with the Curatio team and the important problem they are solving, it became evident that Curatio’s platform undeniably leads to better patient outcomes, which we believe is the ultimate measure for success.
“The combination of rapidly evolving market needs, an exceptional team, and their proven ability to partner with world-class healthcare organizations makes us very excited to be working with Curatio. On a more human level, we deeply believe in Curatio’s mission of “no patient alone”; our belief is that the future of patient therapy is omni-channel: physical, pharmaceutical, and digital.” Fraser Hall, Rhino Managing Partner
Founded in 2013 by Lynda Brown-Ganzert and Alireza Davoodi, the company licenses their platform to hospitals, insurers, research organizations, patient advocacy groups, non-profits, and pharmaceutical manufacturers around the world that are desperately in need of virtual healthcare solutions, especially during COVID-19. Used by some of the largest healthcare companies in the world, Curatio has won numerous awards and widespread industry recognition for the way it combines social support and disease management with AI, machine learning, and virtual patient monitoring.